Our round-up of counterfeit
developments from around the world includes news of Russian police
cracking a $15m counterfeit cancer drug ring, plus updates from the
USA, China and Tanzania.
Police in
Russia have broken up a criminal
organisation thought to have sold 500m roubles ($15m) worth of
counterfeit and expired cancer medicines to pharmacies and
hospitals across the country. Two gang members have been arrested
and face up to 10 years in jail if convicted, according to the
RIA Novosti news agency. The gang reportedly
imported expired medicines from Ukraine, re-packed them and then
sold them on, and also manufactured their own counterfeits,
according to police. They sold the drugs on at prices ranging from
$150 to $615 per ampoule, says the news agency.
Meanwhile, re-interpretation of Russia's Criminal Code could leave
producers and distributors of counterfeit medicines open to charges
of attempted murder, according to an article published by the
Russian legal information agency
RAPSI. The newswire
notes that the country's Economic Security and Anti-Corruption
Committee head, Irina Yarovaya, is recommending that the panel
re-categorise the offense.
In the
USA, the Bulk Pharmaceuticals Task Force
(BPTF) has hailed the passage of the Food and Drug Administration
Safety and Innovation Act as a "turning point in the fight to
eliminate contaminated or counterfeit drug products from consumer
shelves". The trade group - part of the Society of Chemical
Manufacturers and Affiliates (SOCMA) - said that "for too long, the
US drug supply has been susceptible to sub-par quality drugs due to
the lack of FDA enforcement of basic drug quality inspections of
foreign facilities". FDASIA will provide increased resources to the
FDA to conduct more inspections of foreign drug ingredient
manufacturers, it said.
Illegal pharmacologically-active compounds have been identified in
a series of healthcare products including various weight-loss
products in
China, according to the
Xinhua news agency, citing the State Food and Drug
Administration (SFDA). The announcement notes that various
pharmaceuticals have been detected in the products, which are sold
as dietary supplements/health foods. Compounds identified by the
SFDA include sibutramine, phenolphthalein and estazolam. The agency
said the illegal products were detected through random sampling
conducted in drug stores nationwide.
Tanzania is now using 11 minilab kits provided by
the Global Pharma Health Fund to try to prevent counterfeit and
substandard drugs entering the country, according to local
newspaper
The Citizen. The kits are a critical tool in the
fight against the trade as the Tanzanian Food and Drug
Administration (TFDA) is operating on a "shoestring budget" and the
problem is "exacerbated by homegrown corruption networks",
according to the article.
©
SecuringIndustry.com